Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
What Matters to Patients: Metabolic Health Beyond Weight Loss
Author(s): Lee Kaplan , Fatima Cody Stanford , Filip Knop , et al Added: 9 months ago
Radcliffe Medical Education bring together a distinguished panel of globally renowned experts who provide guidance on navigating the ever-changing landscape of obesity and metabolic health management. Under the chairmanship of Prof Jason Halford(University of Leeds, UK), the panel includingDr Lee Kaplan(Obesity, Metabolism and Nutrition Institute, Massachusetts General Hospital, US),Dr… View more

Prevention & Chronic Conditions
Author(s): Ephraim B Beck , Claudia Walther , Antje Körner , et al Added: 3 years ago
In developed countries cardiovascular diseases – including coronary heart disease with acute myocardial infarction and ischaemic heart failure, stroke and chronic cerebrovascular disease, aortic aneurysm, valve disease and peripheral arterial occlusive disease – are by far the main cause of death. Since first cardiovascular events are usually seen in mid-life and old age, atherosclerosis has long… View more

Prevention & Chronic Conditions
EASD 22: SURMOUNT-MMO: Tirepatide in Obese Type II Diabetes Patients
Author(s): Steven E Nissen Added: 1 year ago
EASD 22 - Dr Steven Nissen (Cleveland Clinic, US) joins us to discuss the findings of the SURMOUNT-MMO trial. This study aimed to evaluate the effect of tirzepatide in type II diabetes patients who have obesity, or are overweight. Questions: 1. What was the rationale behind this study? 2. What is the mechanism of action of Tirzepatide? 3. What was the study design? 4. What were the main outcomes… View more

Prevention & Chronic Conditions
Job title: Director of the Obesity, Metabolism & Nutrition Institute
Dr Lee Kaplan is Director of the Obesity, Metabolism & Nutrition Institute, founding director of the Weight Center at the Massachusetts General Hospital, and associate professor of medicine at Harvard Medical School. Dr Kaplan's clinical expertise is in the areas of obesity medicine, gastroenterology and liver disease. The author of more than 150 medical and scientific papers, he has a special… View more
Neha Pagidipati
Job title: Assistant Professor of Medicine
Neha J Pagidipati is an Assistant Professor of Medicine and cardiovascular disease prevention specialist. Since 2011, she has conducted research on cardiometabolic disease prevention, lifestyle modification and weight management. She is currently an NIH K12 scholar in Implementation and Dissemination Science. Dr Pagidipati is building the Duke Cardiometabolic Disease Prevention Program, which… View more
RF
Author(s): Roland Asmar , , , et al Start date: Feb 08, 2022

Prevention & Chronic Conditions
Job title: Advocate for Obesity; EPCO Secretary
Susie Birney lives with a food disorder called ARFID; she understands that there is not only one cause for obesity and not one treatment which will always work. Type 2 Diabetes and other co-morbidities have been health barriers for her since her 30’s. Since 2016, Susie has been a patient representative with the ASOI and an Irish representative with ECPO. This led to the start of creating a… View more
Author(s): Denise Hilfiker-Kleiner , Gerald S Werner , Gerd Heusch Added: 3 years ago
A Cathepsin D-Cleaved 16kDa Form of Prolactin Mediates Postpartum Cardiomyopathy Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. Cell, 2007;128(3):589–600 Postpartum cardiomyopathy (PPCM) is a disease of unknown aetiology exposing women to high risk of mortality after delivery. This study shows that female mice with a cardiomyocyte-specific deletion of STAT3 develop PPCM. In these mice,… View more

Heart Failure
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Author(s): Sotirios Tsalamandris , Alexios S Antonopoulos , Evangelos Oikonomou , et al Added: 3 years ago
Diabetes is a multifaceted metabolic disorder affecting the glucose status of the human body. Impaired glucose tolerance and hyperglycaemia are the main clinical and diagnostic features and the result of an absolute or relative insulin deficiency or resistance to its action. Chronic hyperglycaemia associated with diabetes can result in end organ dysfunction and failure which can involve the… View more

Prevention & Chronic Conditions
AHA 23: Preventive Cardiology in 2023
Author(s): Michael Honigberg Added: 4 months ago
AHA 23 — Dr Michael Honigberg (Massachusetts General Hospital, US) highlights key 2023 cardiology updates, featuring novel data from AHA Scientific Sessions.Dr Honigberg provides commentary on the new SELECT trial outcomes and emphasises the incretin mimetic, semaglutide's role in cardiovascular medicine. He delves into lipid management with a focus on the CLEAR trial data and the incorporation… View more

Standards & Guidelines

Prevention & Chronic Conditions